Stay updated on Safety Study of AFM11 in NHL Clinical Trial
Sign up to get notified when there's something new on the Safety Study of AFM11 in NHL Clinical Trial page.

Latest updates to the Safety Study of AFM11 in NHL Clinical Trial page
- CheckyesterdayChange DetectedDifference0.3%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the study's purpose and detailed inclusion and exclusion criteria for patients with relapsed B-Cell Non-Hodgkin Lymphoma. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference40%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check44 days agoChange DetectedDifference0.3%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Safety Study of AFM11 in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Study of AFM11 in NHL Clinical Trial page.